Immunovant annual revenue
2023
2024
2025
2026
Immunovant Revenue Growth & History (IMVT)
Immunovant reported $0 in revenue for fiscal 2026.
View full Immunovant company overviewImmunovant annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $0 | $0 | — |
| 2025 | 2025-03-31 | $0 | $0 | — |
| 2024 | 2024-03-31 | $0 | $0 | — |
| 2023 | 2023-03-31 | $0 | — | — |
Immunovant quarterly revenue
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $0 | $0 | — |
| Q4 2026 | 2026-03-31 | $0 | — | — |
| Q3 2026 | 2025-12-31 | $0 | — | — |
| Q2 2026 | 2025-09-30 | $0 | — | — |
| Q1 2026 | 2025-06-30 | $0 | — | — |
Immunovant revenue growth trends
Immunovant's latest reported quarter, Q1 2027, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Immunovant source filings ↗